E-LIB Suche - Ergebnisse für: Hashemi-Meshkini, Amir

1

Determinants and economic burden of HIV/AIDS in Iran: a pro..:

Reshadat-Hajiabad, Tahmineh ; Khajavi, Alireza ; Hosseinpour, Ali Mohammad...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012526/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Cost-Effectiveness Comparison between Ticagrelor and Clopid..:

Hashemi-Meshkini, Amir ; Tajik, Amirmohammad ; Ayati, Nayyereh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459340/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Pharmaceutical laws and regulations in Iran: An overview:

Zaboli, Pardis ; Hashemi-Meshkini, Amir ; Varmaghani, Mehdi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966232/. , 2016

Link: http://www.ncbi.nlm.nih...

4

Developing a patient satisfaction questionnaire for service..:

Yaghoubifard, Saeed ; Rashidian, Arash ; Kebriaeezadeh, Abbas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843579/. , 2016

Link: http://www.ncbi.nlm.nih...

5

Making the Public Health and Industrial Objectives Balanced..:

HASHEMI-MESHKINI, Amir
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449421/. , 2014

Link: http://www.ncbi.nlm.nih...

6

A systematic cost-effectiveness analysis of pregabalin in t..:

Keshavarz, Khosro ; Hashemi-Meshkini, Amir ; Gharibnaseri, Zahra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902716. , 2013

Link: http://www.ncbi.nlm.nih...

7

Pharmacists Remuneration Models in Iran and Selected Countr..:

Hashemi-Meshkini, Amir ; Keshavarz, Khosro ; Nikfar, Shekoufeh..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920713. , 2013

Link: http://www.ncbi.nlm.nih...

8

Cost-effectiveness analysis review of exemestane in the tre..:

Hashemi-Meshkini, Amir ; Keshavarz, Khosro ; Gharibnaseri, Zahra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701982. , 2013

Link: http://www.ncbi.nlm.nih...

9

Determinants and economic burden of HIV/AIDS in Iran: a pro..:

Tahmineh Reshadat-Hajiabad ; Alireza Khajavi ; Ali Mohammad Hosseinpour...
https://doi.org/10.1186/s12913-023-09229-6. , 2023

Link: https://doi.org/10.1186/..

10

Cost-Effectiveness Comparison between Ticagrelor and Clopid..:

Amir Hashemi-meshkini ; Amirmohammad Tajik ; Nayyereh Ayati...
https://jthc.tums.ac.ir/index.php/jthc/article/view/1800. , 2023

Link: https://doi.org/10.18502..

11

Everolimus and temsirolimus are not the same second-line in..:

Zahra Goudarzi ; Mehrdad Mostafavi ; Mahmood Salesi...
https://doi.org/10.1186/s12962-023-00420-4. , 2023

Link: https://doi.org/10.1186/..

12

Evaluation of COVID-19 treatments in Iran in comparison wit..:

Amir Hashemi-Meshkini ; Reza Koochak ; Shekoufeh Nikfar..
http://www.jrpp.net/article.asp?issn=2319-9644;year=2022;volume=11;issue=1;spage=1;epage=7;aulast=Hashemi-Meshkini. , 2022

Link: https://doi.org/10.4103/..

13

Pharmaceutical laws and regulations in Iran: An overview:

Pardis Zaboli ; Amir Hashemi-Meshkini ; Mehdi Varmaghani...
http://www.jrpp.net/article.asp?issn=2319-9644;year=2016;volume=5;issue=3;spage=155;epage=161;aulast=Zaboli. , 2016

Link: https://doi.org/10.4103/..

14

Developing a patient satisfaction questionnaire for service..:

Saeed Yaghoubifard ; Arash Rashidian ; Abbas Kebriaeezadeh...
http://www.jrpp.net/article.asp?issn=2319-9644;year=2016;volume=5;issue=2;spage=106;epage=115;aulast=Yaghoubifard. , 2016

Link: https://doi.org/10.4103/..

15

Evaluation of productivity in Iranian pharmaceutical compan..:

Mehdi Varmaghani ; Amir Hashemi Meshkini ; Farshad Farzadfar...
http://www.jrpp.net/article.asp?issn=2319-9644;year=2015;volume=4;issue=2;spage=51;epage=56;aulast=Varmaghani. , 2015

Link: https://doi.org/10.4103/..